Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 9,971

The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Open access
Hindricks, Gerhard, Potpara, Tatjana, Dagres, Nikolaos, Arbelo, Elena, Bax, Jeroen J, Blomström-Lundqvist, Carina, Boriani, Giuseppe, Castella, Manuel, Dan, Gheorghe-Andrei, Dilaveris, Polychronis E, Fauchier, Laurent, Filippatos, Gerasimos, Kalman, Jonathan M, La Meir, Mark, Lane, Deirdre A, Lebeau, Jean-Pierre, Lettino, Maddalena, Lip, Gregory Y H, Pinto, Fausto J, Thomas, G Neil, Valgimigli, Marco, Van Gelder, Isabelle C, Van Putte, Bart P, Watkins, Caroline L, ESC Scientific Document Group, Kirchhof, Paulus, Kühne, Michael, Aboyans, Victor, Ahlsson, Anders, Balsam, Pawel, Bauersachs, Johann, Benussi, Stefano, Brandes, Axel, Braunschweig, Frieder, Camm, A John, Capodanno, Davide, Casadei, Barbara, Conen, David, Crijns, Harry J G M, Delgado, Victoria, Dobrev, Dobromir, Drexel, Heinz, Eckardt, Lars, Fitzsimons, Donna, Folliguet, Thierry, Gale, Chris P, Gorenek, Bulent, Haeusler, Karl Georg, Heidbuchel, Hein, Iung, Bernard, Katus, Hugo A, Kotecha, Dipak, Landmesser, Ulf, Leclercq, Christophe, Lewis, Basil S, Mascherbauer, Julia, Merino, Jose Luis, Merkely, Béla, Mont, Lluís, Mueller, Christian, Nagy, Klaudia V, Oldgren, Jonas, Pavlović, Nikola, Pedretti, Roberto F E, Petersen, Steffen E, Piccini, Jonathan P, Popescu, Bogdan A, Pürerfellner, Helmut, Richter, Dimitrios J, Roffi, Marco, Rubboli, Andrea, Scherr, Daniel, Schnabel, Renate B, Simpson, Iain A, Shlyakhto, Evgeny, Sinner, Moritz F, Steffel, Jan, Sousa-Uva, Miguel, Suwalski, Piotr, Svetlosak, Martin, Touyz, Rhian M, Dagres, Nikolaos, Arbelo, Elena, Bax, Jeroen J, Blomström-Lundqvist, Carina, Boriani, Giuseppe, Castella, Manuel, Dan, Gheorghe-Andrei, Dilaveris, Polychronis E, Fauchier, Laurent, Filippatos, Gerasimos, Kalman, Jonathan M, La Meir, Mark, Lane, Deirdre A, Lebeau, Jean-Pierre, Lettino, Maddalena, Lip, Gregory Y H, Pinto, Fausto J, Neil Thomas, G, Valgimigli, Marco, Van Gelder, Isabelle C, Watkins, Caroline L, Delassi, Tahar, Sisakian, Hamayak S, Scherr, Daniel, Chasnoits, Alexandr, Pauw, Michel De, Smajić, Elnur, Shalganov, Tchavdar, Avraamides, Panayiotis, Kautzner, Josef, Gerdes, Christian, Alaziz, Ahmad Abd, Kampus, Priit, Raatikainen, Pekka, Boveda, Serge, Papiashvili, Giorgi, Eckardt, Lars, Vassilikos, Vassilios, Csanádi, Zoltán, Arnar, David O, Galvin, Joseph, Barsheshet, Alon, Caldarola, Pasquale, Rakisheva, Amina, Bytyçi, Ibadete, Kerimkulova, Alina, Kalejs, Oskars, Njeim, Mario, Puodziukynas, Aras, Groben, Laurent, Sammut, Mark A, Grosu, Aurel, Boskovic, Aneta, Moustaghfir, Abdelhamid, Groot, Natasja de, Poposka, Lidija, Anfinsen, Ole-Gunnar, Mitkowski, Przemyslaw P, Cavaco, Diogo Magalhães, Siliste, Calin, Mikhaylov, Evgeny N, Bertelli, Luca, Kojic, Dejan, Hatala, Robert, Fras, Zlatko, Arribas, Fernando, Juhlin, Tord, Sticherling, Christian, Abid, Leila, Atar, Ilyas, Sychov, Oleg, Bates, Matthew G D, Zakirov, Nodir U·2021·European Heart Journal

Abstract

International audience

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehaa612

Cites

226 of 226 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 226 references

Research works printed but not linked: 1261

  1. Calkins, 2018, 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary, Europace, 20, 157, 10.1093/europace/eux275 · DOI · Paper page
  2. Freedman, 2017, Management of atrial high-rate episodes detected by cardiac implanted electronic devices, Nat Rev Cardiol, 14, 701, 10.1038/nrcardio.2017.94 · DOI
  3. Perino, 2019, Practice variation in anticoagulation prescription and outcomes after device-detected atrial fibrillation, Circulation, 139, 2502, 10.1161/CIRCULATIONAHA.118.038988 · DOI
  4. Steinberg, 2018, Thirty-second gold standard definition of atrial fibrillation and its relationship with subsequent arrhythmia patterns: analysis of a large prospective device database, Circ Arrhythm Electrophysiol, 11, e006274, 10.1161/CIRCEP.118.006274 · DOI
  5. Camm, 2017, Atrial high-rate episodes and stroke prevention, Europace, 19, 169, 10.1093/europace/euw279 · DOI
  6. Pollak, 2001, Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial fibrillation and flutter, Pacing Clin Electrophysiol, 24, 424, 10.1046/j.1460-9592.2001.00424.x · DOI
  7. Kaufman, 2012, Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT, Heart Rhythm, 9, 1241, 10.1016/j.hrthm.2012.03.017 · DOI · Paper page
  8. Colilla, 2013, Estimates of current and future incidence and prevalence of atrial fibrillation in the US adult population, Am J Cardiol, 112, 1142, 10.1016/j.amjcard.2013.05.063 · DOI · Paper page
  9. Krijthe, 2013, Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060, Eur Heart J, 34, 2746, 10.1093/eurheartj/eht280 · DOI · Paper page
  10. Dewland, 2013, Incident atrial fibrillation among Asians, Hispanics, blacks, and whites, Circulation, 128, 2470, 10.1161/CIRCULATIONAHA.113.002449 · DOI · Paper page
  11. Staerk, 2017, Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes, Circ Res, 120, 1501, 10.1161/CIRCRESAHA.117.309732 · DOI · Paper page
  12. Alonso, 2009, Incidence of atrial fibrillation in whites and African Americans: the Atherosclerosis Risk in Communities (ARIC) study, Am Heart J, 158, 111, 10.1016/j.ahj.2009.05.010 · DOI · Paper page
  13. Chao, 2018, Lifetime risks, projected numbers, and adverse outcomes in Asian patients with atrial fibrillation: a report from the Taiwan Nationwide AF Cohort Study, Chest, 153, 453, 10.1016/j.chest.2017.10.001 · DOI · Paper page
  14. Di Carlo, 2019, Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project, Europace, 21, 1468, 10.1093/europace/euz141 · DOI
  15. Mou, 2018, Lifetime risk of atrial fibrillation by race and socioeconomic status: ARIC study (Atherosclerosis Risk in Communities, Circ Arrhythm Electrophysiol, 11, e006350, 10.1161/CIRCEP.118.006350 · DOI · Paper page
  16. Boriani, 2015, Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making – a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society, Europace, 17, 1169, 10.1093/europace/euv202 · DOI · Paper page
  17. Aune, 2018, Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies, J Diabetes Complications, 32, 501, 10.1016/j.jdiacomp.2018.02.004 · DOI · Paper page
  18. Hobbelt, 2017, Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study, Europace, 19, 226
  19. Nalliah, 2018, The impact of diet and lifestyle on atrial fibrillation, Curr Cardiol Rep, 20, 137, 10.1007/s11886-018-1082-8 · DOI
  20. Lip, 2017, Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE), Europace, 19, 891, 10.1093/europace/eux091 · DOI · Paper page
  21. Gallagher, 2017, Alcohol and incident atrial fibrillation – a systematic review and meta-analysis, Int J Cardiol, 246, 46, 10.1016/j.ijcard.2017.05.133 · DOI · Paper page
  22. Ricci, 2018, Physical activity volume in relation to risk of atrial fibrillation. A non-linear meta-regression analysis, Eur J Prev Cardiol, 25, 857, 10.1177/2047487318768026 · DOI
  23. Magnussen, 2017, Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: results from the BiomarCaRE Consortium (, Biomarker for Cardiovascular Risk Assessment in Europe). Circulation, 136, 1588
  24. Staerk, 2018, Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study, BMJ, 361, k1453, 10.1136/bmj.k1453 · DOI · Paper page
  25. Allan, 2017, Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants, Thromb Haemost, 117, 837, 10.1160/TH16-11-0825 · DOI · Paper page
  26. Feghaly, 2018, Genetics of atrial fibrillation, J Am Heart Assoc, 7, e009884, 10.1161/JAHA.118.009884 · DOI
  27. Alonso, 2014, Association of sick sinus syndrome with incident cardiovascular disease and mortality: the Atherosclerosis Risk in Communities Study and Cardiovascular Health Study, PLoS One, 9, e109662, 10.1371/journal.pone.0109662 · DOI
  28. Alonso, 2011, Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study, Circulation, 123, 2946, 10.1161/CIRCULATIONAHA.111.020982 · DOI · Paper page
  29. Andersen, 2013, Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study, Eur Heart J, 34, 3624, 10.1093/eurheartj/eht188 · DOI · Paper page
  30. Asad, 2018, Obesity is associated with incident atrial fibrillation independent of gender: a meta-analysis, J Cardiovasc Electrophysiol, 29, 725, 10.1111/jce.13458 · DOI
  31. Aune, 2017, Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies, Eur J Epidemiol, 32, 181, 10.1007/s10654-017-0232-4 · DOI · Paper page
  32. Bansal, 2017, eGFR and albuminuria in relation to risk of incident atrial fibrillation: a meta-analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study, Clin J Am Soc Nephrol, 12, 1386, 10.2215/CJN.01860217 · DOI
  33. Baumgartner, 2017, Thyroid Studies Collaboration. Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation, Circulation, 136, 2100, 10.1161/CIRCULATIONAHA.117.028753 · DOI · Paper page
  34. Bunch, 2015, Long-term natural history of adult Wolff-Parkinson-White syndrome patients treated with and without catheter ablation, Circ Arrhythm Electrophysiol, 8, 1465, 10.1161/CIRCEP.115.003013 · DOI
  35. Chang, 2017, Association of a family history of atrial fibrillation with incidence and outcomes of atrial fibrillation: a population-based family cohort study, JAMA Cardiol, 2, 863, 10.1001/jamacardio.2017.1855 · DOI
  36. Chen, 2016, Carotid intima-media thickness and arterial stiffness and the risk of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study, Multi-Ethnic Study of Atherosclerosis (MESA), and the Rotterdam Study, J Am Heart Assoc, 5, 10.1161/JAHA.115.002907 · DOI
  37. Cheng, 2009, Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block, JAMA, 301, 2571, 10.1001/jama.2009.888 · DOI · Paper page
  38. Conen, 2010, Caffeine consumption and incident atrial fibrillation in women, Am J Clin Nutr, 92, 509, 10.3945/ajcn.2010.29627 · DOI
  39. Desai, 2019, The burden and impact of arrhythmia in chronic obstructive pulmonary disease: insights from the National Inpatient Sample, Int J Cardiol, 281, 49, 10.1016/j.ijcard.2019.01.074 · DOI
  40. Giacomantonio, 2013, A systematic review of the health benefits of exercise rehabilitation in persons living with atrial fibrillation, Can J Cardiol, 29, 483
  41. Kirchhof, 2012, Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options – a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference, Europace, 14, 8, 10.1093/europace/eur241 · DOI · Paper page
  42. Ko, 2019, Proteomics profiling and risk of new-onset atrial fibrillation: Framingham Heart Study, J Am Heart Assoc, 8, e010976, 10.1161/JAHA.118.010976 · DOI
  43. Kwok, 2014, Physical activity and incidence of atrial fibrillation: a systematic review and meta-analysis, Int J Cardiol, 177, 467, 10.1016/j.ijcard.2014.09.104 · DOI
  44. Lip, 2017, Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: executive summary of a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE), Thromb Haemost, 117, 2215, 10.1160/TH-17-10-0709 · DOI
  45. Loomba, 2017, Arrhythmias in adults with congenital heart disease: what are risk factors for specific arrhythmias?, Pacing Clin Electrophysiol, 40, 353, 10.1111/pace.12983 · DOI
  46. Lubitz, 2010, Association between familial atrial fibrillation and risk of new-onset atrial fibrillation, JAMA, 304, 2263, 10.1001/jama.2010.1690 · DOI · Paper page
  47. May, 2016, Outcomes of Sleep Disorders in Older Men) Study Group. Central sleep-disordered breathing predicts incident atrial fibrillation in older men, Am J Respir Crit Care Med, 193, 783, 10.1164/rccm.201508-1523OC · DOI
  48. Michniewicz, 2018, Patients with atrial fibrillation and coronary artery disease – double trouble, Adv Med Sci, 63, 30, 10.1016/j.advms.2017.06.005 · DOI · Paper page
  49. Monrad, 2017, Long-term exposure to traffic-related air pollution and risk of incident atrial fibrillation: a cohort study, Environ Health Perspect, 125, 422, 10.1289/EHP392 · DOI
  50. O'Neal, 2015, Coronary artery calcium progression and atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis, Circ Cardiovasc Imaging, 8
  51. Qureshi, 2015, Al-Mallah MH. Cardiorespiratory fitness and risk of incident atrial fibrillation: results from the Henry Ford Exercise Testing (FIT) Project, Circulation, 131, 1827, 10.1161/CIRCULATIONAHA.114.014833 · DOI · Paper page
  52. Santhanakrishnan, 2016, Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction, Circulation, 133, 484, 10.1161/CIRCULATIONAHA.115.018614 · DOI · Paper page
  53. Shen, 2011, Dietary factors and incident atrial fibrillation: the Framingham Heart Study, Am J Clin Nutr, 93, 261, 10.3945/ajcn.110.001305 · DOI
  54. Svensson, 2017, Psychological stress and risk of incident atrial fibrillation in men and women with known atrial fibrillation genetic risk scores, Sci Rep, 7, 42613, 10.1038/srep42613 · DOI
  55. Tung, 2017, Obstructive and central sleep apnea and the risk of incident atrial fibrillation in a community cohort of men and women, J Am Heart Assoc, 6, 10.1161/JAHA.116.004500 · DOI
  56. Walkey, 2013, Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors, Am Heart J, 165, 949, 10.1016/j.ahj.2013.03.020 · DOI
  57. Lip, 2020, Evaluation of the C2HEST risk score as a possible opportunistic screening tool for incident atrial fibrillation in a healthy population (from a nationwide Danish cohort study), Am J Cardiol, 125, 48, 10.1016/j.amjcard.2019.09.034 · DOI
  58. Yiin, 2018, Time trends in atrial fibrillation-associated stroke and premorbid anticoagulation, Stroke, STROKEAHA118022249
  59. Akao, 2013, Current status of clinical background of patients with atrial fibrillation in a community-based survey: the Fushimi AF Registry, J Cardiol, 61, 260, 10.1016/j.jjcc.2012.12.002 · DOI · Paper page
  60. An, 2019, Causes of death in Japanese patients with atrial fibrillation: the Fushimi Atrial Fibrillation Registry, Eur Heart J Qual Care Clin Outcomes, 5, 35, 10.1093/ehjqcco/qcy033 · DOI
  61. Andersson, 2013, All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case-control study, Eur Heart J, 34, 1061, 10.1093/eurheartj/ehs469 · DOI · Paper page
  62. Andrew, 2013, The prevalence, impact and economic implications of atrial fibrillation in stroke: what progress has been made?, Neuroepidemiology, 40, 227, 10.1159/000343667 · DOI
  63. Bakhai, 2016, Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry, Eur Heart J Qual Care Clin Outcomes, 2, 299, 10.1093/ehjqcco/qcw031 · DOI
  64. Benjamin, 1998, Impact of atrial fibrillation on the risk of death: the Framingham Heart Study, Circulation, 98, 946, 10.1161/01.CIR.98.10.946 · DOI · Paper page
  65. Blum, 2017, Prospective assessment of sex-related differences in symptom status and health perception among patients with atrial fibrillation, J Am Heart Assoc, 6, e005401, 10.1161/JAHA.116.005401 · DOI
  66. Boriani, 2015, Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry, Am J Med, 128, 509, 10.1016/j.amjmed.2014.11.026 · DOI · Paper page
  67. Ceornodolea, 2017, Epidemiology and management of atrial fibrillation and stroke: review of data from four European countries, Stroke Res Treat, 2017, 8593207
  68. Chao, 2016, Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation: a nationwide cohort study, Stroke, 47, 2462, 10.1161/STROKEAHA.116.013880 · DOI
  69. Dagres, 2018, European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?, EP Europace, 20, 1399, 10.1093/europace/euy046 · DOI
  70. Esato, 2017, Clinical impact of asymptomatic presentation status in patients with paroxysmal and sustained atrial fibrillation: the Fushimi AF Registry, Chest, 152, 1266, 10.1016/j.chest.2017.08.004 · DOI
  71. Freeman, 2015, Association between atrial fibrillation symptoms, quality of life, and patient outcomes: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF), Circ Cardiovasc Qual Outcomes, 8, 393, 10.1161/CIRCOUTCOMES.114.001303 · DOI · Paper page
  72. Frost, 2001, Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation, Arch Intern Med, 161, 272, 10.1001/archinte.161.2.272 · DOI
  73. Gaita, 2013, Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function, J Am Coll Cardiol, 62, 1990, 10.1016/j.jacc.2013.05.074 · DOI · Paper page
  74. Garcia-Fernandez, 2017, Applicability of the modified CHA2DS2-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients, Eur J Intern Med, 38, e21, 10.1016/j.ejim.2016.11.006 · DOI
  75. Gleason, 2018, Atrial fibrillation symptoms and sex, race, and psychological distress: a literature review, J Cardiovasc Nurs, 33, 137, 10.1097/JCN.0000000000000421 · DOI
  76. Gomez-Outes, 2016, Causes of death in anticoagulated patients with atrial fibrillation, J Am Coll Cardiol, 68, 2508, 10.1016/j.jacc.2016.09.944 · DOI · Paper page
  77. Graves, 2017, Atrial fibrillation incrementally increases dementia risk across all CHADS2 and CHA2DS2VASc strata in patients receiving long-term warfarin, Am Heart J, 188, 93, 10.1016/j.ahj.2017.02.026 · doi:10.1016/j.ahj.2017.02.026
  78. John, 2018, Atrial fibrillation hospitalization, mortality, and therapy, Eur Heart J, 39, 3958, 10.1093/eurheartj/ehy622 · DOI
  79. Kalantarian, 2016, Atrial fibrillation and cognitive decline: phenomenon or epiphenomenon?, Cardiol Clin, 34, 279
  80. Kalantarian, 2013, Cognitive impairment associated with atrial fibrillation: a meta-analysis, Ann Intern Med, 158, 338, 10.7326/0003-4819-158-5-201303050-00007 · DOI · Paper page
  81. Kim, 2011, Estimation of total incremental health care costs in patients with atrial fibrillation in the United States, Circ Cardiovasc Qual Outcomes, 4, 313, 10.1161/CIRCOUTCOMES.110.958165 · DOI · Paper page
  82. Kochhauser, 2016, The impact of duration of atrial fibrillation recurrences on measures of health-related quality of life and symptoms, Pacing Clin Electrophysiol, 39, 166, 10.1111/pace.12772 · DOI
  83. Konig, 2018, In-hospital mortality of patients with atrial arrhythmias: insights from the German-wide Helios hospital network of 161 502 patients and 34 025 arrhythmia-related procedures, Eur Heart J, 39, 3947, 10.1093/eurheartj/ehy528 · DOI
  84. Kotecha, 2016, Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins, J Am Coll Cardiol, 68, 2217, 10.1016/j.jacc.2016.08.048 · DOI · Paper page
  85. Kupper, 2018, Type D personality affects health-related quality of life in patients with lone atrial fibrillation by increasing symptoms related to sympathetic activation, J Psychosom Res, 115, 44, 10.1016/j.jpsychores.2018.10.005 · DOI
  86. Kwok, 2011, Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis, Neurology, 76, 914, 10.1212/WNL.0b013e31820f2e38 · DOI · Paper page
  87. Levy, 1999, Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists, Circulation, 99, 3028, 10.1161/01.CIR.99.23.3028 · DOI · Paper page
  88. Lin, 1996, Stroke severity in atrial fibrillation. The Framingham Study, Stroke, 27, 1760, 10.1161/01.STR.27.10.1760 · DOI · Paper page
  89. Lip, 2015, Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot Survey on Atrial Fibrillation, Europace, 17, 24, 10.1093/europace/euu155 · DOI · Paper page
  90. McCabe, 2015, Patients’ experiences from symptom onset to initial treatment for atrial fibrillation, J Clin Nurs, 24, 786, 10.1111/jocn.12708 · DOI
  91. McCabe, 2011, Living with atrial fibrillation: a qualitative study, J Cardiovasc Nurs, 26, 336, 10.1097/JCN.0b013e31820019b9 · DOI
  92. Meyre, 2019, Risk of hospital admissions in patients with atrial fibrillation: a systematic review and meta-analysis, Can J Cardiol, 35, 1332
  93. Nieuwlaat, 2005, Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation, Eur Heart J, 26, 2422, 10.1093/eurheartj/ehi505 · DOI · Paper page
  94. Overvad, 2017, Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score, Eur Heart J Cardiovasc Pharmacother, 3, 37, 10.1093/ehjcvp/pvw022 · DOI
  95. Piccini, 2016, Rhythm control in atrial fibrillation, Lancet, 388, 829, 10.1016/S0140-6736(16)31277-6 · DOI
  96. Pistoia, 2016, The epidemiology of atrial fibrillation and stroke, Cardiol Clin, 34, 255
  97. Pokorney, 2016, Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF, J Am Heart Assoc, 5, e002197, 10.1161/JAHA.115.002197 · DOI · Paper page
  98. Potpara, 2013, A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study, Int J Cardiol, 168, 4744, 10.1016/j.ijcard.2013.07.234 · DOI
  99. Randolph, 2016, Patient factors associated with quality of life in atrial fibrillation, Am Heart J, 182, 135, 10.1016/j.ahj.2016.08.003 · DOI
  100. Rienstra, 2012, Symptoms and functional status of patients with atrial fibrillation: state-of-the-art and future research opportunities, Circulation, 125, 2933, 10.1161/CIRCULATIONAHA.111.069450 · DOI · Paper page
  101. Rienstra, 2014, Asymptomatic persistent atrial fibrillation and outcome: results of the RACE study, Heart Rhythm, 11, 939, 10.1016/j.hrthm.2014.03.016 · DOI
  102. Rivard, 2017, Mechanisms, clinical significance, and prevention of cognitive impairment in patients with atrial fibrillation, Can J Cardiol, 33, 1556
  103. Santangeli, 2012, Atrial fibrillation and the risk of incident dementia: a meta-analysis, Heart Rhythm, 9, 1761, 10.1016/j.hrthm.2012.07.026 · DOI · Paper page
  104. Schnabel, 2013, Depression in atrial fibrillation in the general population, PLoS One, 8, e79109, 10.1371/journal.pone.0079109 · DOI
  105. Schnabel, 2017, Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation, Heart, 103, 1024, 10.1136/heartjnl-2016-310406 · DOI · Paper page
  106. Senoo, 2012, Distribution of first-detected atrial fibrillation patients without structural heart diseases in symptom classifications, Circ J, 76, 1020, 10.1253/circj.CJ-12-0105 · DOI
  107. Serpytis, 2018, Impact of atrial fibrillation on cognitive function, psychological distress, quality of life, and impulsiveness, Am J Med, 131, 703.e1-703, 10.1016/j.amjmed.2017.12.044 · DOI
  108. Siontis, 2016, Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: characteristics and prognostic implications, Heart Rhythm, 13, 1418, 10.1016/j.hrthm.2016.03.003 · DOI · Paper page
  109. Steg, 2012, Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry, Heart, 98, 195, 10.1136/heartjnl-2011-300550 · DOI
  110. Streur, 2017, Symptom clusters in adults with chronic atrial fibrillation, J Cardiovasc Nurs, 32, 296, 10.1097/JCN.0000000000000344 · DOI
  111. Thrall, 2007, Depression, anxiety, and quality of life in patients with atrial fibrillation, Chest, 132, 1259, 10.1378/chest.07-0036 · DOI · Paper page
  112. Ugowe, 2019, Jackson LRn. Atrial fibrillation and mortality risk: seeing the big picture, Eur Heart J Qual Care Clin Outcomes, 5, 6, 10.1093/ehjqcco/qcy050 · DOI
  113. Vermond, 2014, Symptom severity is associated with cardiovascular outcome in patients with permanent atrial fibrillation in the RACE II study, Europace, 16, 1417, 10.1093/europace/euu151 · DOI
  114. Walters, 2018, Psychological distress and suicidal ideation in patients with atrial fibrillation: prevalence and response to management strategy, J Am Heart Assoc, 7, e005502, 10.1161/JAHA.117.005502 · DOI
  115. Walters, 2019, Symptom severity and quality of life in patients with atrial fibrillation: psychological function outweighs clinical predictors, Int J Cardiol, 279, 84, 10.1016/j.ijcard.2018.10.101 · DOI
  116. Wang, 2003, A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study, JAMA, 290, 1049, 10.1001/jama.290.8.1049 · DOI · Paper page
  117. Wijesurendra, 2015, Atrial fibrillation: effects beyond the atrium?, Cardiovasc Res, 105, 238, 10.1093/cvr/cvv001 · DOI
  118. Ziff, 2018, The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: insights from the United Kingdom ACALM registry, Int J Cardiol, 252, 117, 10.1016/j.ijcard.2017.06.033 · DOI
  119. Sepehri Shamloo, 2020, Atrial fibrillation and cognitive impairment: new insights and future directions, Heart Lung Circ, 29, 69, 10.1016/j.hlc.2019.05.185 · DOI
  120. Conen, 2019, Relationships of overt and silent brain lesions with cognitive function in patients with atrial fibrillation, J Am Coll Cardiol, 73, 989, 10.1016/j.jacc.2018.12.039 · DOI · Paper page
  121. Kirchhof, 2016, 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur Heart J, 37, 2893, 10.1093/eurheartj/ehw210 · DOI · Paper page
  122. Boriani, 2014, AF burden is important – fact or fiction?, Int J Clin Pract, 68, 444, 10.1111/ijcp.12326 · DOI
  123. Boriani, 2016, Atrial fibrillation burden and atrial fibrillation type: clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation, Vascul Pharmacol, 83, 26, 10.1016/j.vph.2016.03.006 · DOI
  124. Wyse, 2014, Lone atrial fibrillation: does it exist?, J Am Coll Cardiol, 63, 1715, 10.1016/j.jacc.2014.01.023 · DOI · Paper page
  125. Lip, 2017, Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE), Europace, 19, 1757, 10.1093/europace/eux240 · DOI
  126. Brieger, 2018, National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the diagnosis and management of atrial fibrillation 2018, Heart Lung Circ, 27, 1209, 10.1016/j.hlc.2018.06.1043 · DOI · Paper page
  127. Chen, 2018, Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association, Circulation, 137, e623, 10.1161/CIR.0000000000000568 · DOI · Paper page
  128. Ziegler, 2006, Comparison of continuous versus intermittent monitoring of atrial arrhythmias, Heart Rhythm, 3, 1445, 10.1016/j.hrthm.2006.07.030 · DOI · Paper page
  129. Boriani, 2018, Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) long-term general registry, Europace, 20, 747, 10.1093/europace/eux301 · DOI · Paper page
  130. Pandey, 2017, Predictors and prognostic implications of incident heart failure in patients with prevalent atrial fibrillation, JACC Heart Fail, 5, 44, 10.1016/j.jchf.2016.09.016 · DOI
  131. Ganesan, 2016, The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis, Eur Heart J, 37, 1591, 10.1093/eurheartj/ehw007 · DOI · Paper page
  132. Al-Khatib, 2013, Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial, Eur Heart J, 34, 2464, 10.1093/eurheartj/eht135 · DOI · Paper page
  133. Link, 2017, Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48, Circ Arrhythm Electrophysiol, 10, e004267, 10.1161/CIRCEP.116.004267 · DOI
  134. Steinberg, 2015, Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial, Eur Heart J, 36, 288, 10.1093/eurheartj/ehu359 · DOI · Paper page
  135. Hart, 2000, Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators, J Am Coll Cardiol, 35, 183, 10.1016/S0735-1097(99)00489-1 · DOI · Paper page
  136. Takabayashi, 2015, Incidence of stroke or systemic embolism in paroxysmal versus sustained atrial fibrillation: the Fushimi Atrial Fibrillation Registry, Stroke, 46, 3354, 10.1161/STROKEAHA.115.010947 · DOI
  137. Nieuwlaat, 2008, Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?, Eur Heart J, 29, 915, 10.1093/eurheartj/ehn101 · DOI
  138. Go, 2018, Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: the KP-RHYTHM Study, JAMA Cardiol, 3, 601, 10.1001/jamacardio.2018.1176 · DOI · Paper page
  139. Ecker, 2018, A review of factors associated with maintenance of sinus rhythm after elective electrical cardioversion for atrial fibrillation, Clin Cardiol, 41, 862, 10.1002/clc.22931 · DOI
  140. Nyong, 2016, Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation, Cochrane Database Syst Rev, 11, CD012088
  141. Piccini, 2019, Atrial fibrillation burden, progression, and the risk of death: a case-crossover analysis in patients with cardiac implantable electronic devices, Europace, 21, 404, 10.1093/europace/euy222 · DOI
  142. Deng, 2017, Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review, Clin Res Cardiol, 106, 813, 10.1007/s00392-017-1123-0 · DOI
  143. Potpara, 2012, A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation Study, Chest, 141, 339, 10.1378/chest.11-0340 · DOI
  144. Goette, 2016, EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication, Europace, 18, 1455, 10.1093/europace/euw161 · DOI · Paper page
  145. Nattel, 2014, Early management of atrial fibrillation to prevent cardiovascular complications, Eur Heart J, 35, 1448, 10.1093/eurheartj/ehu028 · DOI · Paper page
  146. Freedman, 2017, Screening for atrial fibrillation: a report of the AF-SCREEN International Collaboration, Circulation, 135, 1851, 10.1161/CIRCULATIONAHA.116.026693 · DOI · Paper page
  147. Mairesse, 2017, Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE, Europace, 19, 1589, 10.1093/europace/eux177 · DOI
  148. Padfield, 2017, Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation, Heart Rhythm, 14, 801, 10.1016/j.hrthm.2017.01.038 · DOI · Paper page
  149. Vidal-Perez, 2013, The change in the atrial fibrillation type as a prognosis marker in a community study: long-term data from AFBAR (Atrial Fibrillation in the BARbanza) study, Int J Cardiol, 168, 2146, 10.1016/j.ijcard.2013.01.261 · DOI
  150. de Vos, 2010, Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis, J Am Coll Cardiol, 55, 725, 10.1016/j.jacc.2009.11.040 · DOI · Paper page
  151. Hobbelt, 2017, Prethrombotic state in young very low-risk patients with atrial fibrillation, J Am Coll Cardiol, 69, 1990, 10.1016/j.jacc.2017.01.057 · doi:10.1016/j.jacc.2017.01.057
  152. Habibi, 2016, Cardiac magnetic resonance-measured left atrial volume and function and incident atrial fibrillation: results from MESA (Multi-Ethnic Study of Atherosclerosis), Circ Cardiovasc Imaging, 9, e004299, 10.1161/CIRCIMAGING.115.004299 · DOI
  153. Guichard, 2017, Atrial Cardiomyopathy: A useful notion in cardiac disease management or a passing fad?, J Am Coll Cardiol, 70, 756, 10.1016/j.jacc.2017.06.033 · DOI · Paper page
  154. Hirsh, 2015, Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences, J Am Coll Cardiol, 65, 2239, 10.1016/j.jacc.2015.03.557 · DOI · Paper page
  155. Freedman, 2016, Stroke prevention in atrial fibrillation, Lancet, 388, 806, 10.1016/S0140-6736(16)31257-0 · DOI · Paper page
  156. Martinez, 2014, Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study, Thromb Haemost, 112, 276, 10.1160/TH4-04-0383 · DOI
  157. Wilson, 1968, [Principles and practice of mass screening for disease], Bol Oficina Sanit Panam, 65, 281
  158. Welton, 2017, Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis, Health Technol Assess, 21, 1, 10.3310/hta21290 · DOI
  159. Schnabel, 2019, Searching for atrial fibrillation poststroke: a white paper of the AF-SCREEN International Collaboration, Circulation, 140, 1834, 10.1161/CIRCULATIONAHA.119.040267 · DOI
  160. Yan, 2018, Contact-free screening of atrial fibrillation by a smartphone using facial pulsatile photoplethysmographic signals, J Am Heart Assoc, 7, 10.1161/JAHA.118.008585 · DOI
  161. Orchard, 2016, Screening for atrial fibrillation during influenza vaccinations by primary care nurses using a smartphone electrocardiograph (iECG): a feasibility study, Eur J Prev Cardiol, 23, 13, 10.1177/2047487316670255 · DOI
  162. Lampert, 2018, Screening for atrial fibrillation using smartphone-based technology and layperson volunteers: high-tech meets community participatory research for the best of both worlds, Heart Rhythm, 15, 1312, 10.1016/j.hrthm.2018.07.005 · DOI
  163. Lahdenoja, 2018, Atrial fibrillation detection via accelerometer and gyroscope of a smartphone, IEEE J Biomed Health Inform, 22, 108, 10.1109/JBHI.2017.2688473 · DOI
  164. Freedman, 2016, Screening for atrial fibrillation using a smartphone: is there an app for that?, J Am Heart Assoc, 5, 10.1161/JAHA.116.004000 · DOI
  165. Brasier, 2019, Detection of atrial fibrillation with a smartphone camera: first prospective, international, two-centre, clinical validation study (DETECT AF PRO), Europace, 21, 41, 10.1093/europace/euy176 · DOI
  166. Tison, 2018, Passive detection of atrial fibrillation using a commercially available smartwatch, JAMA Cardiol, 3, 409, 10.1001/jamacardio.2018.0136 · DOI · Paper page
  167. Li, 2019, The current state of mobile phone apps for monitoring heart rate, heart rate variability, and atrial fibrillation: narrative review, JMIR Mhealth Uhealth, 7, e11606, 10.2196/11606 · DOI
  168. Wasserlauf, 2019, Smartwatch performance for the detection and quantification of atrial fibrillation, Circ Arrhythm Electrophysiol, 12, e006834, 10.1161/CIRCEP.118.006834 · DOI · Paper page
  169. Harris, 2012, How can we best detect atrial fibrillation?, J R Coll Physicians Edinb, 42 Suppl 18, 5, 10.4997/JRCPE.2012.S02. · DOI
  170. Wiesel, 2004, The use of a modified sphygmomanometer to detect atrial fibrillation in outpatients, Pacing Clin Electrophysiol, 27, 639, 10.1111/j.1540-8159.2004.00499.x · DOI
  171. Wiesel, 2009, Detection of atrial fibrillation using a modified microlife blood pressure monitor, Am J Hypertens, 22, 848, 10.1038/ajh.2009.98 · DOI
  172. Stergiou, 2009, Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation, J Hum Hypertens, 23, 654, 10.1038/jhh.2009.5 · DOI
  173. Willits, 2014, WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension: a, NICE Medical Technology Guidance. Appl Health Econ Health Policy, 12, 255, 10.1007/s40258-014-0096-7 · DOI
  174. Desteghe, 2017, Performance of handheld electrocardiogram devices to detect atrial fibrillation in a cardiology and geriatric ward setting, Europace, 19, 29
  175. Kaasenbrood, 2016, Yield of screening for atrial fibrillation in primary care with a hand-held, single-lead electrocardiogram device during influenza vaccination, Europace, 18, 1514, 10.1093/europace/euv426 · DOI
  176. Jacobs, 2018, Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands, Europace, 20, 12
  177. Lowres, 2014, Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study, Thromb Haemost, 111, 1167, 10.1160/TH14-03-0231 · DOI · Paper page
  178. Nemati, 2016, Monitoring and detecting atrial fibrillation using wearable technology, Conf Proc IEEE Eng Med Biol Soc, 2016, 3394
  179. Petryszyn, 2019, Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis, PLoS One, 14, e0213198, 10.1371/journal.pone.0213198 · DOI
  180. Orchard, 2018, Atrial fibrillation: is there enough evidence to recommend opportunistic or systematic screening?, Int J Epidemiol, 47, 1361, 10.1093/ije/dyy156 · DOI
  181. Turakhia, 2015, Economic burden of undiagnosed nonvalvular atrial fibrillation in the United States, Am J Cardiol, 116, 733, 10.1016/j.amjcard.2015.05.045 · DOI
  182. Fay, 2017, Screening of older patients for atrial fibrillation in general practice: current evidence and its implications for future practice, Eur J Gen Pract, 23, 246, 10.1080/13814788.2017.1374366 · DOI
  183. Boriani, 2015, Asymptomatic lone atrial fibrillation – how can we detect the arrhythmia?, Curr Pharm Des, 21, 659, 10.2174/1381612820666140825142639 · doi:10.2174/1381612820666140825142639
  184. Lowres, 2013, Screening to identify unknown atrial fibrillation. A systematic review, Thromb Haemost, 110, 213, 10.1160/TH13-02-0165 · DOI · Paper page
  185. Engdahl, 2013, Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention, Circulation, 127, 930, 10.1161/CIRCULATIONAHA.112.126656 · DOI · Paper page
  186. Boriani, 2014, Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices), Eur Heart J, 35, 508, 10.1093/eurheartj/eht491 · DOI · Paper page
  187. Lowres, 2015, Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation, Int J Clin Pharm, 37, 1111, 10.1007/s11096-015-0169-1 · DOI
  188. Wynn, 2014, The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification, Europace, 16, 965, 10.1093/europace/eut395 · DOI · Paper page
  189. De With, 2019, Targeted therapy of underlying conditions improves quality of life in patients with persistent atrial fibrillation: results of the RACE 3 study, Europace, 21, 563, 10.1093/europace/euy311 · DOI
  190. Schnabel, 2018, Symptom burden of atrial fibrillation and its relation to interventions and outcome in Europe, J Am Heart Assoc, 7, 10.1161/JAHA.117.007559 · DOI
  191. Björkenheim, 2017, Assessment of atrial fibrillation – specific symptoms before and 2 years after atrial fibrillation ablation: do patients and physicians differ in their perception of symptom relief?, JACC: Clinical Electrophysiology, 3, 1168
  192. Sandhu, 2017, Impact of electrical cardioversion on quality of life for the treatment of atrial fibrillation, Can J Cardiol, 33, 450
  193. Gilbert, 2015, Restoration of sinus rhythm results in early and late improvements in the functional reserve of the heart following direct current cardioversion of persistent AF: FRESH-AF, Int J Cardiol, 199, 121, 10.1016/j.ijcard.2015.07.020 · doi:10.1016/j.ijcard.2015.07.020
  194. Jais, 2008, Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study, Circulation, 118, 2498, 10.1161/CIRCULATIONAHA.108.772582 · DOI · Paper page
  195. Oral, 2006, Circumferential pulmonary-vein ablation for chronic atrial fibrillation, N Engl J Med, 354, 934, 10.1056/NEJMoa050955 · DOI · Paper page
  196. Wilber, 2010, Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial, JAMA, 303, 333, 10.1001/jama.2009.2029 · DOI · Paper page
  197. Pokorney, 2017, Cardioversion and subsequent quality of life and natural history of atrial fibrillation, Am Heart J, 185, 59, 10.1016/j.ahj.2016.10.018 · DOI
  198. Mantovan, 2013, Relationship of quality of life with procedural success of atrial fibrillation (AF) ablation and postablation AF burden: substudy of the STAR AF randomized trial, Can J Cardiol, 29, 1211
  199. Blomstrom-Lundqvist, 2019, Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial, JAMA, 321, 1059, 10.1001/jama.2019.0335 · DOI · Paper page
  200. Mark, 2019, Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial, JAMA, 10.1001/jama.2019.0692 · DOI · Paper page

200 of 1261 shown

Cited by

See all 9,971

Metadata

Authors
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., Fauchier, L., Filippatos, G., Kalman, J. M., La Meir, M., Lane, D. A., Lebeau, J.-P., Lettino, M., Lip, G. Y. H., Pinto, F. J., Thomas, G. N., Valgimigli, M., Van Gelder, I. C., Van Putte, B. P., Watkins, C. L., ESC Scientific Document Group, Kirchhof, P., Kühne, M., Aboyans, V., Ahlsson, A., Balsam, P., Bauersachs, J., Benussi, S., Brandes, A., Braunschweig, F., Camm, A. J., Capodanno, D., Casadei, B., Conen, D., Crijns, H. J. G. M., Delgado, V., Dobrev, D., Drexel, H., Eckardt, L., Fitzsimons, D., Folliguet, T., Gale, C. P., Gorenek, B., Haeusler, K. G., Heidbuchel, H., Iung, B., Katus, H. A., Kotecha, D., Landmesser, U., Leclercq, C., Lewis, B. S., Mascherbauer, J., Merino, J. L., Merkely, B., Mont, L., Mueller, C., Nagy, K. V., Oldgren, J., Pavlović, N., Pedretti, R. F. E., Petersen, S. E., Piccini, J. P., Popescu, B. A., Pürerfellner, H., Richter, D. J., Roffi, M., Rubboli, A., Scherr, D., Schnabel, R. B., Simpson, I. A., Shlyakhto, E., Sinner, M. F., Steffel, J., Sousa-Uva, M., Suwalski, P., Svetlosak, M., Touyz, R. M., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., Fauchier, L., Filippatos, G., Kalman, J. M., La Meir, M., Lane, D. A., Lebeau, J.-P., Lettino, M., Lip, G. Y. H., Pinto, F. J., Neil Thomas, G., Valgimigli, M., Van Gelder, I. C., Watkins, C. L., Delassi, T., Sisakian, H. S., Scherr, D., Chasnoits, A., Pauw, M. D., Smajić, E., Shalganov, T., Avraamides, P., Kautzner, J., Gerdes, C., Alaziz, A. A., Kampus, P., Raatikainen, P., Boveda, S., Papiashvili, G., Eckardt, L., Vassilikos, V., Csanádi, Z., Arnar, D. O., Galvin, J., Barsheshet, A., Caldarola, P., Rakisheva, A., Bytyçi, I., Kerimkulova, A., Kalejs, O., Njeim, M., Puodziukynas, A., Groben, L., Sammut, M. A., Grosu, A., Boskovic, A., Moustaghfir, A., Groot, N. D., Poposka, L., Anfinsen, O.-G., Mitkowski, P. P., Cavaco, D. M., Siliste, C., Mikhaylov, E. N., Bertelli, L., Kojic, D., Hatala, R., Fras, Z., Arribas, F., Juhlin, T., Sticherling, C., Abid, L., Atar, I., Sychov, O., Bates, M. G. D., & Zakirov, N. U.
Venue
European Heart Journal
Published
2020-08-29
Volume
42
Issue
5
Pages
373-498
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W3082188176
Cited by
9,971
References
226
FWCI
832.50
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). https://app.cochat.ai/papers/10.1093/eurheartj/ehaa612
The paper
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., Fauchier, L., Filippatos, G., Kalman, J. M., La Meir, M., Lane, D. A., Lebeau, J.-P., Lettino, M., Lip, G. Y. H., Pinto, F. J., . . . Zakirov, N. U. (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. https://doi.org/10.1093/eurheartj/ehaa612

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.